Antonio A.
- Country
- Spain
- Department
- Servicio Neumología
Research Overview
- Phase 2 Randomized Double‑Blind Study of VX-828/Deutivacaftor With and Without Tezacaftor in Adults with Cystic Fibrosis
- Evaluation of Long-term Safety and Efficacy of Tezacaftor, Deutivacaftor, and Vanzacaftor Combination Therapy in Patients with Cystic Fibrosis
- Long-term Safety and Efficacy Evaluation of Inhaled Lentiviral Vector Gene Therapy BI 3720931 in Cystic Fibrosis Patients from Previous Clinical Trial
Data & Insights
Has run more than one trial at 94 of 233 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on bronchiectasis and cystic fibrosis. Their research focuses on innovative therapeutic approaches for managing these chronic respiratory disorders.
- Non-CF Bronchiectasis
- Cystic Fibrosis Bronchiectasis
- Chronic Respiratory Care
The investigator's work encompasses long-term treatment strategies and safety monitoring for respiratory conditions.
Novel Therapeutics Development
Expertise in evaluating emerging treatments for respiratory diseases, including CFTR modulators and inhaled therapeutics. The investigator's research includes assessment of various therapeutic compounds for treating genetic respiratory conditions.
- Experimental Respiratory Medicines
- Inhalation Therapy
- Treatment Safety Profiles
Their work involves testing both single and combination therapies for respiratory conditions.
Clinical Assessment
Specializes in evaluating treatment tolerability and lung function improvements in patients with genetic respiratory disorders. The investigator's expertise includes monitoring long-term health outcomes and treatment effectiveness.
- Safety Monitoring
- Therapeutic Efficacy
- Patient Response Assessment
Focus includes comprehensive evaluation of treatment outcomes in respiratory medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.